XTL BIOPHARMACEUTICALS LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2020-12-31: Form 6-K; Period of report 2020-12-31; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea132527-6k_xtlbiopharma.htm.
- 2020-11-25: Form 6-K; Period of report 2020-11-25; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea130488-6k_xtlbiopharm.htm.
- 2020-11-12: Form 6-K; Period of report 2020-11-12; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea129690-6k_xtlbiopharma.htm.
- 2020-08-24: Form 6-K; Period of report 2020-08-24; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea125921-6k_xtlbiopharma.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2020-12-31 | 6-K | 2020-12-31 | REPORT OF FOREIGN PRIVATE ISSUER | ea132527-6k_xtlbiopharma.htm |
| 2020-11-25 | 6-K | 2020-11-25 | REPORT OF FOREIGN PRIVATE ISSUER | ea130488-6k_xtlbiopharm.htm |
| 2020-11-12 | 6-K | 2020-11-12 | REPORT OF FOREIGN PRIVATE ISSUER | ea129690-6k_xtlbiopharma.htm |
| 2020-08-24 | 6-K | 2020-08-24 | REPORT OF FOREIGN PRIVATE ISSUER | ea125921-6k_xtlbiopharma.htm |
| 2020-07-07 | 6-K | 2020-07-07 | REPORT OF FOREIGN PRIVATE ISSUER | ea123861-6k_xtlbiopharma.htm |
| 2020-06-30 | 6-K | 2020-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | ea123579-6k_xtlbiopharma.htm |
| 2020-05-27 | 6-K | 2020-05-27 | REPORT OF FOREIGN PRIVATE ISSUER | ea122330-6k_xtlbiopharm.htm |
| 2020-05-26 | 6-K | 2020-05-26 | REPORT OF FOREIGN PRIVATE ISSUER | ea122283-6k_xtlbiopharma.htm |
| 2020-05-26 | 6-K | 2020-05-26 | REPORT OF FOREIGN PRIVATE ISSUER | ea122258-6k_xtlbiopharma.htm |
| 2020-01-29 | 6-K | 2020-01-29 | REPORT OF FOREIGN PRIVATE ISSUER | f6k012920_xtlbiopharma.htm |
| 2020-01-22 | 6-K | 2020-01-22 | CURRENT REPORT OF FOREIGN ISSUER | f6k012220_xtlbiopharma.htm |
| 2020-01-13 | 6-K/A | 2020-01-13 | AMENDMENT NO. 1 TO FORM 6-K | f6k011320a1_xtlbiopharma.htm |